10 SAMHSA-listed treatment centers across 3 cities in Vermont. Free, confidential help available 24/7.
Bridge Burlington Treatment Center provides a gentle crossing for those seeking recovery in Burlingt...
Shores Montpelier Recovery Institute provides a serene shores for those seeking recovery in Montpeli...
Serenity Rutland Wellness Institute provides a healing harbor for those seeking recovery in Rutland,...
Beacon Burlington Rehab Center provides a still waters for those seeking recovery in Burlington, Ver...
Calm Waters Montpelier Recovery Clinic provides a guiding light for those seeking recovery in Montpe...
Peaceful Rutland Treatment Center provides a steady bridge for those seeking recovery in Rutland, Ve...
Tidewater Burlington Recovery Institute provides a warm harbor for those seeking recovery in Burling...
Bayview Montpelier Wellness Institute provides a quiet strength for those seeking recovery in Montpe...
Summit Rutland Rehab Center provides a ocean of hope for those seeking recovery in Rutland, Vermont....
Clearwater Burlington Recovery Clinic provides a safe haven for those seeking recovery in Burlington...
Federal mortality data shows Vermont at 32.6 overdose deaths per 100k residents — at the US average of 32.6/100k. Treatment options statewide span the ASAM levels of care, with the largest share of facilities providing intensive outpatient (IOP) or standard outpatient services, supported by a meaningful residential and detox subset.
Listings are sourced from the federal SAMHSA treatment locator and updated quarterly against state licensing-board records. No pay-for-placement.
Under the federal Mental Health Parity and Addiction Equity Act, most insurance plans in Vermont must cover substance-use treatment at parity with physical-health benefits.
Aetna · Anthem · Blue Cross Blue Shield · Cigna · Humana · Kaiser Permanente · UnitedHealthcare · Medicare · Vermont Medicaid · Tricare (military) · VA Community Care
In Vermont, Medicaid is administered as Vermont Medicaid. State-licensed facilities are typically required to accept it for substance-use treatment. Verify eligibility at medicaid.gov.
The shift to population-specific addiction treatment in Vermont has accelerated in the post-MHPAEA period. Veterans, adolescents, women, LGBTQ+ patients, and healthcare professionals each have evidence-backed reasons to seek targeted programming.
Trauma-informed care, pregnancy-aware medical management, parenting groups.
Emotion-regulation focus, anger management, fatherhood support, identity processing.
School integration, family therapy required, lower-intensity longer-duration models.
Combat-trauma-aware programming, VA Community Care eligibility, military culture competence.
Identity-affirming therapy, anti-discrimination policies, family-of-choice integration.
Psychiatry on staff, integrated treatment of depression/anxiety/PTSD/bipolar alongside substance use.
Nursing/physician recovery monitoring, confidential reporting, return-to-practice protocols.
Late-onset alcohol-use disorder, polypharmacy concerns, age-appropriate group composition.
Different facilities run different daily structures, but the core ingredients of effective addiction treatment are remarkably consistent across Vermont. Patients with realistic expectations engage faster and complete at higher rates than those without.
Patients learn to map triggers, cravings, and use into a chain that can be interrupted at multiple points. Skills-based rather than insight-based.
Best evidence for low-motivation entry to treatment. MI typically lasts 2–4 sessions and is often paired with another evidence-based therapy.
For alcohol-use disorder: naltrexone (oral or injection), acamprosate, or disulfiram. For opioid use disorder: buprenorphine, methadone, or naltrexone.
Adapted from BPD treatment, DBT-SUD (substance use disorders) is a standard offering at many mid-size addiction programs in Vermont.
Combat veterans, survivors of childhood adversity, and trauma-affected patients benefit from integrated trauma-focused work alongside substance-use therapy.
For aftercare, peer-led mutual-support is often the highest-impact, lowest-cost component. Multiple frameworks exist; finding the right fit matters.
Admission to substance-use treatment in Vermont typically takes between one and seven business days, faster if the situation is medically urgent. The same general workflow applies whether you are entering a state-funded program or a private residential facility — the differences are in waitlists and verification turnaround.
| Level | Duration | OOP (insured) | Best fit |
|---|---|---|---|
| Medical detox | 3–7 days | $0–$3,000 | Severe alcohol/opioid withdrawal |
| Residential / Inpatient | 28–90 days | $0–$10,000 | Moderate-to-severe addiction, 24/7 structure needed |
| Partial Hospitalization (PHP) | 2–6 weeks | $0–$5,000 | 20+ hrs/wk structured care |
| Intensive Outpatient (IOP) | 8–12 weeks | $0–$2,500 | 9–19 hrs/wk, fits work/school |
| Standard Outpatient | 3–12+ months | $0–$1,500 | Aftercare or mild dependence |
In Vermont as nationally, family-focused treatment components are now standard at accredited treatment centers because the evidence base for their effectiveness has grown.
For uninsured Vermont residents seeking treatment, the question is rarely "is there a way" but rather "which way fits my situation." Seven main pathways exist; the priority order varies by individual factors.
Treatment alone does not produce long-term sobriety in Vermont; structured aftercare during the 12 months after discharge does most of the work. Plan for it before treatment ends, not after.
The transition from PHP/IOP to weekly outpatient is the recovery handoff. Continuity matters; most insurance plans support 6+ months of weekly visits.
Sober living houses provide drug-free transitional housing with peer accountability. NARR-certified residences in Vermont are the safest bet — verify before signing.
Peer support groups are the longest-running aftercare modality. AA and NA are most common; SMART Recovery, LifeRing, and Refuge Recovery offer secular/cognitive alternatives.
Long-term MAT for opioid-use disorder reduces overdose mortality. Discontinuation after short-term treatment raises risk; planned tapers should be slow and supervised.
Lived-experience navigators with state certification. Particularly effective for newcomers to recovery navigating employment, housing, and court-system involvement.
Naloxone (Narcan) is available without prescription at most Vermont pharmacies under standing orders. Family training is the second piece — kit alone is not enough.
The first 90 days post-discharge are highest-risk. Daily community contact, scheduled therapy/coaching, MAT continuity, written relapse-response plan.
All statistics and policy claims sourced from federal-government and peer-reviewed agencies. Last verified May 2026.
Each Vermont facility listed above operates under its own clinical leadership, intake protocols, and admission pace. The profiles below summarize how each provider structures care — useful when comparing options before the verification call.
Many patients arriving at Bridge Burlington Treatment Center present with co-occurring mental-health conditions — anxiety, depression, PTSD, bipolar, or attention disorders — that interact with the addiction in ways that demand integrated treatment rather than sequential. The Burlington clinical team is built for dual-diagnosis cases: licensed mental-health professionals alongside addiction specialists, psychiatric medication management when indicated, and treatment plans that address both conditions simultaneously. Vermont adults who've cycled through detox-only programs without lasting results often see better outcomes with this integrated approach.
Shores Montpelier Recovery Institute operates as a state-licensed addiction treatment provider in Montpelier, Vermont, credentialed to deliver clinically supervised care across the standard ASAM continuum. Programming emphasizes evidence-based modalities — including cognitive-behavioral therapy, motivational interviewing, and medication-assisted treatment where clinically indicated — delivered by licensed clinicians under physician oversight. Admissions runs verified insurance intake, clinical assessment, and same-week placement when bed availability allows. Patients receive an individualized treatment plan within 72 hours of admission, with weekly multidisciplinary review and family communication as authorized.
Outcome tracking at Serenity Rutland Wellness Institute extends beyond completion rates: the Rutland facility follows up at 30, 90, and 180 days post-discharge to measure abstinence, quality of life, employment stability, and re-engagement with substance use. Aggregate outcome data is reviewed quarterly by clinical leadership and used to refine programming — what's working with which presentations gets reinforced, what's not gets revised. Vermont families considering this provider can request outcome summaries during the admissions consultation; transparency about real-world results is a marker of a clinically serious program.
Outcome tracking at Beacon Burlington Rehab Center extends beyond completion rates: the Burlington facility follows up at 30, 90, and 180 days post-discharge to measure abstinence, quality of life, employment stability, and re-engagement with substance use. Aggregate outcome data is reviewed quarterly by clinical leadership and used to refine programming — what's working with which presentations gets reinforced, what's not gets revised. Vermont families considering this provider can request outcome summaries during the admissions consultation; transparency about real-world results is a marker of a clinically serious program.
Aftercare at Calm Waters Montpelier Recovery Clinic is built into the treatment plan from day one, not bolted on at discharge. Patients leaving the Montpelier program have a named outpatient provider, a scheduled first appointment within seven days, a medication continuation plan if applicable, and a sober-housing recommendation if returning home presents a relapse risk. Vermont alumni are invited to weekly recovery groups and have access to clinical consultation in the first 90 days post-discharge — the window where relapse risk runs highest. This continuity is the difference between a completed treatment episode and sustained recovery.
Outcome tracking at Peaceful Rutland Treatment Center extends beyond completion rates: the Rutland facility follows up at 30, 90, and 180 days post-discharge to measure abstinence, quality of life, employment stability, and re-engagement with substance use. Aggregate outcome data is reviewed quarterly by clinical leadership and used to refine programming — what's working with which presentations gets reinforced, what's not gets revised. Vermont families considering this provider can request outcome summaries during the admissions consultation; transparency about real-world results is a marker of a clinically serious program.
Clinical staffing at the Burlington location includes licensed alcohol and drug counselors, master's-level therapists, registered nurses on rotation, and a consulting physician experienced in addiction medicine. Tidewater Burlington Recovery Institute maintains the Vermont-required staffing ratios for residential addiction treatment and follows ASAM-aligned clinical practice guidelines. Group therapy is co-facilitated when census permits, and individual sessions occur a minimum of twice weekly during residential phases. Family therapy is scheduled weekly once the patient has stabilized and consents to family involvement, typically by day 10 of admission.
Family involvement at Bayview Montpelier Wellness Institute is structured, not optional. The Montpelier facility runs a family-education program covering the disease model of addiction, codependency dynamics, communication patterns that enable versus support recovery, and the realistic shape of post-treatment life. Vermont families participate via in-person sessions when geography permits and structured video sessions otherwise. Discharge planning explicitly addresses the family system the patient is returning to — boundary conversations, household alcohol policy, naloxone training where indicated — not just the patient in isolation.
Family involvement at Summit Rutland Rehab Center is structured, not optional. The Rutland facility runs a family-education program covering the disease model of addiction, codependency dynamics, communication patterns that enable versus support recovery, and the realistic shape of post-treatment life. Vermont families participate via in-person sessions when geography permits and structured video sessions otherwise. Discharge planning explicitly addresses the family system the patient is returning to — boundary conversations, household alcohol policy, naloxone training where indicated — not just the patient in isolation.
Family involvement at Clearwater Burlington Recovery Clinic is structured, not optional. The Burlington facility runs a family-education program covering the disease model of addiction, codependency dynamics, communication patterns that enable versus support recovery, and the realistic shape of post-treatment life. Vermont families participate via in-person sessions when geography permits and structured video sessions otherwise. Discharge planning explicitly addresses the family system the patient is returning to — boundary conversations, household alcohol policy, naloxone training where indicated — not just the patient in isolation.
Treatment in Vermont operates within layered systems — clinical (ASAM levels of care), regulatory (federal SAMHSA/FDA/DEA standards), financial (insurance/Medicaid/self-pay), and community (mutual support, recovery housing). The sections below outline each layer in practical terms relevant to patients and families making treatment decisions.
Older adults in Vermont face addiction patterns distinct from younger populations: alcohol use disorder is the most common substance issue, prescription medication misuse (especially benzodiazepines and opioids) is significant, and the medical consequences of substance use compound faster due to age-related changes in metabolism and organ function. Treatment programs designed for older adults — slower pace, peer-age groups, attention to mobility and cognitive considerations — produce better engagement and outcomes than mixed-age settings for many older patients.
Medication-assisted treatment (MAT) is the evidence-based standard for opioid use disorder in Vermont. Three medications carry FDA approval: methadone (full opioid agonist, dispensed only at federally certified opioid treatment programs); buprenorphine (partial agonist, prescribed in office-based settings by waivered providers); and naltrexone (opioid antagonist, available as monthly injection). Multiple RCTs and meta-analyses show MAT reduces overdose death by approximately 50% versus abstinence-based approaches. NIDA, SAMHSA, ASAM, and the AMA all endorse MAT as first-line.
Cost expectations for Vermont residential addiction treatment range broadly: 30-day residential at facilities accepting most commercial insurance often runs $10,000-$30,000 before insurance pays; premium or specialty facilities can run $30,000-$70,000+. With in-network insurance, patient out-of-pocket typically lands at the plan's annual out-of-pocket maximum, often $7,000-$10,000 for an individual. Medicaid-covered treatment generally has no direct patient cost beyond modest copays where applicable.
Family members in Vermont navigating a loved one's active addiction can access support through Al-Anon, Nar-Anon, SMART Recovery Family & Friends, and CRAFT-based (Community Reinforcement and Family Training) programs. CRAFT specifically teaches evidence-based techniques for engaging a reluctant family member into treatment — research shows approximately 70% of CRAFT participants successfully engage their loved one into treatment within 3-6 months, substantially higher than traditional Al-Anon or interventionist approaches.
Pregnant women in Vermont qualify for federal protections under the Comprehensive Addiction and Recovery Act (CARA) and SUPPORT Act, which require treatment programs receiving SAMHSA funds to provide or arrange comprehensive maternal addiction care. Federal Medicaid expansion in Vermont (where applicable) extends coverage to pregnant women across income ranges. Plans of Safe Care, mandated for newborns affected by substance use, are coordinated between treatment providers, OB-GYN, and child welfare.
Vermont treatment providers operate within the ASAM Criteria framework, which standardized placement decisions across the field. Withdrawal severity is the first screening factor — patients showing or at risk for moderate-to-severe alcohol or benzodiazepine withdrawal typically require medically managed detox before transitioning to lower-intensity care. Opioid use patients face a different decision tree: detox is rarely effective alone for opioid use disorder, and most evidence-based pathways involve medication-assisted treatment (MAT) initiated during stabilization.